Literature DB >> 8214902

Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease.

J M Lapointe1, J P Lavoie, A A Vrins.   

Abstract

Effects of triamcinolone acetonide (TA) on pulmonary function, bronchoalveolar lavage cytologic features and serum cortisol concentration, were studied in 5 control horses and 5 horses with chronic obstructive pulmonary disease (COPD). In experiment 1, horses were brought in from pasture 3 weeks before administration of 1 injection of TA (0.09 mg/kg of body weight, IM), and were stabled in dusty conditions throughout the experimental period. Measurements of respiratory rate (f), tidal volume, minute ventilation, expiratory-to-inspiratory time ratio, maximal change in transpulmonary pressure (delta PL), pulmonary resistance (RL), and dynamic compliance (Cdyn) were obtained during quiet breathing, immediately before (baseline) and 1, 2, 3, 5, and 9 weeks after administration of TA. Pulmonary airway cells were collected by bronchoalveolar lavage while horses were at pasture, at baseline, and 2, 5, and 9 weeks after TA administration. Serum cortisol concentration was measured before and after adrenocortical stimulation with 100 IU of adrenocorticotropic hormone, 1 week prior to TA administration, and 4 and 8 weeks thereafter. In experiment 2, 4 months after TA injection, pulmonary function measurements were repeated in all horses immediately before and 30 minutes after administration of atropine (0.015 mg/kg, IV), to evaluate the reversibility of airway obstruction. In experiment 1 at baseline, COPD-affected horses had significantly (P < 0.05) higher values than did controls for f, delta PL, RL, and percentage of neutrophils, and had lower values for Cdyn and percentage of lymphocytes and macrophages. There was significant reductions in delta PL and RL, and increase in macrophage percentage after TA administration in COPD-affected horses only.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214902

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Inflammatory Airway Disease of Horses--Revised Consensus Statement.

Authors:  L L Couëtil; J M Cardwell; V Gerber; J-P Lavoie; R Léguillette; E A Richard
Journal:  J Vet Intern Med       Date:  2016-01-24       Impact factor: 3.333

2.  Tracheal microbial populations in horses with moderate asthma.

Authors:  Estelle Manguin; Elizabeth Pépin; Roxane Boivin; Mathilde Leclere
Journal:  J Vet Intern Med       Date:  2020-01-27       Impact factor: 3.333

3.  Effect of Dexamethasone and Fluticasone on Airway Hyperresponsiveness in Horses With Inflammatory Airway Disease.

Authors:  R Léguillette; T Tohver; S L Bond; J A Nicol; K J McDonald
Journal:  J Vet Intern Med       Date:  2017-05-31       Impact factor: 3.333

Review 4.  Equine asthma: Integrative biologic relevance of a recently proposed nomenclature.

Authors:  Stephanie Bond; Renaud Léguillette; Eric A Richard; Laurent Couetil; Jean-Pierre Lavoie; James G Martin; R Scott Pirie
Journal:  J Vet Intern Med       Date:  2018-10-07       Impact factor: 3.333

5.  Efficacy of inhaled budesonide for the treatment of severe equine asthma.

Authors:  J P Lavoie; M Leclere; N Rodrigues; K R Lemos; C Bourzac; J Lefebvre-Lavoie; G Beauchamp; B Albrecht
Journal:  Equine Vet J       Date:  2018-09-25       Impact factor: 2.888

6.  Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial.

Authors:  Robert Scott Pirie; Hanns-Walter Mueller; Odilo Engel; Balazs Albrecht; Marcella von Salis-Soglio
Journal:  Equine Vet J       Date:  2021-01-28       Impact factor: 2.888

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.